Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders

Data to Support Alzheimer’s Study ENGLEWOOD CLIFFS, NJ, April 19, 2023 (GLOBE…

Silo Pharma Announces Expansion of Intellectual Property Portfolio

Silo Receives Issuance of U.S. Patent Covering SPC-15 Method for Treatment and…